Log in
Enquire now
BridgeBio

BridgeBio

BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
AngelList URL
angel.co/company/bridgebio
B2X
B2B
B2B
Board of Directors
Andrew Lo
Andrew Lo
5
‌
Richard Scheller
5
Brenton L. Saunders
Brenton L. Saunders
5
Neil Kumar
Neil Kumar
5
Hannah Valantine
Hannah Valantine
5
‌
Douglas Dachille
5
Randy Scott
Randy Scott
5
Jennifer Cook
Jennifer Cook
5
‌
Eric Aguiar
5
‌
Charles Homcy
5
•••
Business Model
Commerce
CAGE Code
8FVJ9
6
CEO
Neil Kumar
Neil Kumar
5
CIK Number
1,743,881
7
Legal Name
BridgeBio Pharma, Inc.
Company Operating Status
Active
Competitors
MyoKardia
MyoKardia
Aimmune Therapeutics
Aimmune Therapeutics
Magenta Therapeutics
Magenta Therapeutics
Mirati Therapeutics
Mirati Therapeutics
vTv Therapeutics
vTv Therapeutics
Kadmon
Kadmon
Quest PharmaTech
Quest PharmaTech
Syros Pharmaceuticals
Syros Pharmaceuticals
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...ridgebio
DUNS Number
117109644
6
Email Address
info@bridgebio.com
Facebook URL
@BridgeBio-Pharma-100543364785856
Founded Date
January 1, 2014
Founder
Neil Kumar
Neil Kumar
Frank McCormick
Frank McCormick
Full Address
421 Kipling St, Palo Alto, California US
Industry
Immunotherapy
Immunotherapy
Genealogy
Genealogy
Genetics
Genetics
Pharmaceutical industry
Pharmaceutical industry
Biomedical engineering
Biomedical engineering
Enzyme kinetics
Enzyme kinetics
Chemistry
Chemistry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
•••
Invested in
MyoKardia
MyoKardia
Investors
Janus Henderson Investors
Janus Henderson Investors
Hercules Capital
Hercules Capital
Perceptive Advisors
Perceptive Advisors
Cormorant Capital
Cormorant Capital
‌
Kohlberg Ventures
KKR
KKR
Sequoia Capital
Sequoia Capital
Viking Global Investors
Viking Global Investors
AIG Investments
AIG Investments
Aisling Capital
Aisling Capital
Latest Funding Round Date
January 2021
Latest Funding Round Amount (USD)
250,000,000
Latest Funding Type
Series D
Series D
Legal classification
Corporation
Corporation
Incorporation (business)
Incorporation (business)
LinkedIn URL
@company/bridgebio
Location
United States
United States
San Francisco
San Francisco
8
North Carolina
North Carolina
Palo Alto, California
Palo Alto, California
Motto/Tagline
Hope Through Rigorous Science
NAICS Code
325,412
9
Number of Employees (Ranges)
51 – 200
Phone Number
+16503919740
Pitchbook URL
pitchbook.com/profiles...165914-74
Place of Incorporation
Delaware
Delaware
7
Previous Name
BridgeBio Pharma LLC
7
SIC Code
2,834
7
Exchange
Nasdaq
Nasdaq
10
Stock Symbol
BBIO
10
Subsidiary
‌
Navire Pharma
Qed Therapeutics
Qed Therapeutics
11
‌
Eidos Therapeutics
Ticker Symbol
BBIO
Total Funding Amount (USD)
1,633,200,000
Twitter URL
@bridgebiopharma
Official Website
bridgebio.com
bridgebiollc.com
Wellfound ID
bridgebio

Find more companies like BridgeBio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.